These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3835116)

  • 1. Observations on the role of vespertilionid bats in relation to non-human vertebrate reservoir in Indian kala-azar.
    Rajendran P; Chatterjee SN; Dhanda V; Dhiman RC
    Indian J Pathol Microbiol; 1985 Apr; 28(2):153-8. PubMed ID: 3835116
    [No Abstract]   [Full Text] [Related]  

  • 2. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis.
    Singh R; Kumar D; Ramesh V; Negi NS; Singh S; Salotra P
    J Infect Dis; 2006 Aug; 194(3):302-6. PubMed ID: 16826477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular characterization of clinical isolates from Indian Kala-azar patients by MLEE and RAPD-PCR.
    Manna M; Majumder HK; Sundar S; Bhaduri AN
    Med Sci Monit; 2005 Jul; 11(7):BR220-7. PubMed ID: 15990683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion transmitted leishmaniasis: a case report and review of literature.
    Dey A; Singh S
    Indian J Med Microbiol; 2006 Jul; 24(3):165-70. PubMed ID: 16912434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of Phlebotomus alexandri in the transmission of kala-azar].
    Guan LR; Xu YX; Li BS; Dong JA
    Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1985; 3(2):85-8. PubMed ID: 4053323
    [No Abstract]   [Full Text] [Related]  

  • 6. Demonstration of Leishmania parasites in skin lesions of Indian post kala-azar dermal leishmaniasis (PKDL) cases.
    Sharma MC; Gupta AK; Verma N; Das VN; Saran R; Kar SK
    J Commun Dis; 2000 Mar; 32(1):67-8. PubMed ID: 11129569
    [No Abstract]   [Full Text] [Related]  

  • 7. Vectorial efficacy of Phlebotomus argentipes in Kala-azar endemic foci of Bihar (India) under natural and artificial conditions.
    Kumar V; Kishore K; Palit A; Keshari S; Sharma MC; Das VN; Shivakumar S; Roy MS; Sinha NK; Prasad M; Kar SK
    J Commun Dis; 2001 Jun; 33(2):102-9. PubMed ID: 12170928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cutaneous parasitism by Leishmania (Leishmania) chagasi during South American visceral leishmaniasis].
    Vasconcelos Ide A; Sousa Ade Q; Vasconcelos AW; Diógenes MJ; Momen H; Grimaldi Júnior G; Menezes DB; Sleigh AC
    Bull Soc Pathol Exot; 1993; 86(2):101-5. PubMed ID: 8353466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A search for Leishmania in normal skin and blood of Kala-Azar patients from Bihar, India.
    Saran R; Gupta AK; Prasad LS
    J Commun Dis; 1988 Mar; 20(1):89-90. PubMed ID: 3230291
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on stibanate resistant Leishmania donovani isolates of Indian origin.
    Pal S; Mandal A; Duttagupta S
    Indian J Exp Biol; 2001 Mar; 39(3):249-54. PubMed ID: 11495284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LD body-negative bone marrow cases of kala-azar in Dharan, Nepal.
    Karki P; Parija SC; Koirala S
    J Commun Dis; 1999 Dec; 31(4):261-2. PubMed ID: 10937305
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic heterogeneity among visceral and post-Kala-Azar dermal leishmaniasis strains from eastern India.
    Dey A; Singh S
    Infect Genet Evol; 2007 Mar; 7(2):219-22. PubMed ID: 17027344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kala-Azar at high altitude.
    Mahajan SK; Machhan P; Kanga A; Thakur S; Sharma A; Prasher BS; Pal LS
    J Commun Dis; 2004 Jun; 36(2):117-20. PubMed ID: 16295673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and laboratory comparison of different brands of amphotericin B used for the treatment of Kala-azar: an observational study.
    Narayan S; Gupta AK; Singh Subhankar K; Lal CS; Singh VP; Sinha PK; Das P; Thakur CP
    J Commun Dis; 2008 Dec; 40(4):273-6. PubMed ID: 19579720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ulcerative post-kala azar mucosal leishmaniasis masquerading as a carcinoma--a case report.
    Toran KC; Sah SP; Joshi A; Rani S
    Indian J Pathol Microbiol; 2003 Jul; 46(3):487-9. PubMed ID: 15025319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cases of kala-azar without any hepatosplenomegaly.
    Parija SC; Karki P; Koirala S
    Trop Doct; 2000 Jul; 30(3):187-8. PubMed ID: 10902492
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphadenopathy in a child with Indian kala-azar in Dharan, Nepal.
    Singh K; Singh R; Parija SC
    Indian Pediatr; 1998 Nov; 35(11):1125-6. PubMed ID: 10216552
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic fingerprinting and identification of differentially expressed genes in isolates of Leishmania donovani from Indian patients of post-kala-azar dermal leishmaniasis.
    Subba Raju BV; Singh R; Sreenivas G; Singh S; Salotra P
    Parasitology; 2008 Jan; 135(Pt 1):23-32. PubMed ID: 17761024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral leishmaniasis with cysticercosis.
    Ray R; Vaiphei K; Datta BN
    J Trop Med Hyg; 1992 Oct; 95(5):331-4. PubMed ID: 1404555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.
    Lira R; Sundar S; Makharia A; Kenney R; Gam A; Saraiva E; Sacks D
    J Infect Dis; 1999 Aug; 180(2):564-7. PubMed ID: 10395884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.